Spravato (Esketamine) Treatment
Introduction
Spravato (esketamine) is an FDA-approved nasal spray for treatment-resistant depression, used alongside an oral antidepressant. Unlike traditional medications that can take weeks to show any effect, many patients notice meaningful improvement in mood within days of starting treatment.
What Contributes to This
Spravato may be a fit if:
- You've tried two or more standard antidepressants without adequate relief
- Depression is significantly affecting your daily functioning despite ongoing treatment
- You and your provider are looking for a faster-acting option alongside therapy and medication
How Can We Help?
Every Spravato treatment is administered in-office under direct clinical supervision, following the FDA-mandated monitoring protocol.
Eligibility Consultation
We review your treatment history together to confirm Spravato is an appropriate, safe next step — and walk through exactly what to expect before your first dose.
Supervised In-Office Dosing
You self-administer the nasal spray in our office under direct observation, then remain on-site for monitoring — the full visit typically runs about two hours.
Built-In Safety Monitoring
Your blood pressure and how you're feeling are checked at regular intervals during the monitoring period, per FDA requirements, before you're cleared to leave with a ride home.
A Coordinated Treatment Plan
Spravato sessions are paired with your ongoing oral antidepressant and therapy, with dosing frequency adjusted over time as your symptoms respond.
